Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Single-cohort, and Multi-center Phase II Study Evaluating Tumor-specific Immunity After Extracorporeal Photopheresis in Patients With Sézary Syndrome at Single-cell Resolution

NCT05157581 is registered in ClinicalTrials.gov with Oleg E. Akilov, MD, PhD as lead sponsor.

NCT NCT05157581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05157581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Single-cohort, and Multi-center Phase II Study Evaluating Tumor-specific Immunity After Extracorporeal Photopheresis in Patients With Sézary Syndrome at Single-cell Resolution
Lead sponsor
Oleg E. Akilov, MD, PhD
Phase
Observational
Overall status
Recruiting
Start date
April 4, 2023
Completion date
December 31, 2028
Enrollment
20 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

sezary syndrome